Article Details
Retrieved on: 2021-12-02 02:53:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley estimates Omicron could generate an additional $20 billion to $50 billion in 2022 revenues, mostly for Pfizer-BioNTech and Moderna, ...
Article found on: www.politico.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here